Entecavir and intermittent etanercept therapy in a patient with concurrent hepatitis B virus infection and psoriasis

Acta Derm Venereol. 2013 May;93(3):373-4. doi: 10.2340/00015555-1477.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage*
  • Drug Administration Schedule
  • Etanercept
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives*
  • Hepatitis B / complications
  • Hepatitis B / diagnosis
  • Hepatitis B / drug therapy*
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Psoriasis / complications
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Receptors, Tumor Necrosis Factor / administration & dosage*
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • entecavir
  • Guanine
  • Etanercept